A late-stage clinical biopharmaceutical company is on a mission to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.
The lead product candidate, lysergide tartrate, represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. The early stage pipeline includes DT402, the R-enantiomer of MDMA, under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges.
Guided by the recognition that patients deserve more than better, the company is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, the aim is to change the trajectory of today's mental health care crisis and enable a healthier future.
Together we are moving psychiatry forward—beyond better, into a boundless future. Join us!
The starting base pay range for this position is $169,814.00 - $192,241.00. Compensation will be determined based on several factors including, but not limited to, skill set, years of experience, and the employee's geographic location.
Employees in this role may be entitled to additional compensation, including bonus and equity. Benefits information is listed on our Jobs Page. The company provides competitive benefits to employees including:
| Location | New York, GA |
| Salary | $169,814–$192,241 Per Year |
Browse dozens of recruiter approved resume templates, layouts and formats. Choose your favorite and make it your own in minutes.
Free resume templatesImprove your existing resume or start from scratch and create a standout, ATS-friendly resume. Add job-specific content, download and apply.
Free resume builder